Pharma News

CVMP initiates review of withdrawal periods of certain tylosin injectable products used in pigs

  • Posted on: 30 January 2019
  • By: Shalini.Sharma

Committee for Medicinal Products for Veterinary Use (CVMP) adopted by consensus a positive opinion for a type II variation application (subject to a worksharing procedure) for Purevax RC, Purevax RCP, Purevax RCP FeLV, Purevax RCPCh FeLV and Purevax RCPCh concerning quality changes.

Investigational monoclonal antibody to treat Ebola is safe in adults : NIH

  • Posted on: 30 January 2019
  • By: Shalini.Sharma

The investigational Ebola treatment mAb114 is safe, well-tolerated, and easy to administer, according to findings from an early-stage clinical trial published in The Lancet. Eighteen healthy adults received the monoclonal antibody as part of a Phase 1 clinical trial that began in May 2018 at the National Institutes of Health (NIH) Clinical Center in Bethesda, Maryland. The National Institute of Allergy and Infectious Diseases (NIAID) Vaccine Research Center (VRC), part of NIH, developed the investigational treatment and conducted and sponsored the clinical trial.

No new patients should start treatment with Lartruvo after study shows cancer medicine does not prolong life: EMA

  • Posted on: 25 January 2019
  • By: Shalini.Sharma

Preliminary results from the ANNOUNCE study show that Lartruvo (olaratumab) in combination with doxorubicin is not more effective at prolonging the lives of patients with soft tissue cancer than doxorubicin alone.

Smoking linked to higher risk of peripheral artery disease in African-Americans : Study

  • Posted on: 25 January 2019
  • By: Shalini.Sharma

African-Americans who smoke appear to be at greater risk for peripheral artery disease, or PAD, new research has found. Additionally, the findings suggest that smoking intensity – how many cigarettes a day and for how many years – also affects the likelihood of getting the disease.

Blood test shows promise for early detection of severe lung-transplant rejection: NIH

  • Posted on: 25 January 2019
  • By: Shalini.Sharma

Researchers have developed a simple blood test that can detect when a newly transplanted lung is being rejected by a patient, even when no outward signs of the rejection are evident. The test could make it possible for doctors to intervene faster to prevent or slow down so-called chronic rejection—which is severe, irreversible, and often deadly—in those first critical months after lung transplantation. Researchers believe this same test might also be useful for monitoring rejection in other types of organ transplants. The work was funded by the National Heart, Lung, and Blood Institute (NHLBI), part of the National Institutes of Health.

FDA permits marketing of first test to aid in the diagnosis of a sexually-transmitted infection known as Mycoplasma genitalium

  • Posted on: 25 January 2019
  • By: Shalini.Sharma

The U.S. Food and Drug Administration permitted marketing of a new test to aid in the diagnosis of a sexually-transmitted infection (STI) called Mycoplasma genitalium (M. gen.). This is the first test authorized by the FDA to test for the M. gen. bacterium, which is associated with inflammation of the urethra (non-gonococcal urethritis) in men and inflammation of the cervix (cervicitis) and infection of the reproductive organs (pelvic inflammatory disease) in women.

Dengue immunity may be protective against symptomatic Zika, study finds

  • Posted on: 25 January 2019
  • By: Shalini.Sharma

Children with a history of prior dengue virus infection had a significantly lower risk of being symptomatic when infected by Zika virus, according to a study in Nicaragua of more than 3,000 children aged 2 to 14 years. Experts have worried that prior dengue virus infection could exacerbate severe Zika disease. However, the new findings, published in PLOS Medicine, indicate that prior dengue immunity in children may in fact be protective against symptomatic Zika disease.

The Global Commission on the Future of Work calls for fundamental changes in health at work: WHO

  • Posted on: 25 January 2019
  • By: Shalini.Sharma

The ILO Global Commission on the Future of Work calls for fundamental changes in the way we work in the new wave of globalization, rapid technological development, demographic transition and climate change, according to its report Work for a Brighter Future published today. The report examines how to achieve a better future of work for all at a time of unprecedented change and exceptional challenges in the world of work.

Apple Inc joined with J&J to improve health outcomes of atrial fibrillation including stroke prevention

  • Posted on: 25 January 2019
  • By: PharmaTutor News

Johnson & Johnson entered into a research study in collaboration with Apple Inc. to investigate whether a new heart health program using an app from Johnson & Johnson in combination with Apple Watch’s irregular rhythm notifications and ECG app can accelerate the diagnosis and improve health outcomes of the 33 million people worldwide living with atrial fibrillation (AFib), a condition that can lead to stroke and other potentially devastating complications. In the U.S. alone, AFib is responsible for approximately 130,000 deaths and 750,000 hospitalizations every year.

Pages